Twist Bioscience (TWST) Net Equity Issued and Repurchased (2017 - 2020)

Twist Bioscience (TWST) has reported Net Equity Issued and Repurchased for 4 consecutive years, with $323.9 million the latest figure, recorded in Q4 2020.

• On a quarterly basis, Net Equity Issued and Repurchased rose 574.79% year-over-year to $323.9 million in Q4 2020; TTM through Jun 2023 was $323.9 million, a 32.42% decrease from a year earlier, with the FY2023 full-year figure at $1.3 billion, changed 0.0% from the prior year.
• Net Equity Issued and Repurchased was $323.9 million for Q4 2020 at Twist Bioscience, up from $107.4 million in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $323.9 million in Q4 2020 and troughed at $3.0 million in Q4 2017.
• A 4-year average of $81.4 million and a median of $48.0 million in 2019 frame the typical range for Net Equity Issued and Repurchased.
• The widest YoY moves for Net Equity Issued and Repurchased: up 574.79% in 2020, down 574.79% in 2020.
• Over 4 years, Net Equity Issued and Repurchased stood at $3.0 million in 2017, then jumped by 133.34% to $7.0 million in 2018, then soared by 587.97% to $48.0 million in 2019, then soared by 574.79% to $323.9 million in 2020.
• The last three Net Equity Issued and Repurchased figures came in at $323.9 million (Q4 2020), $107.4 million (Q2 2020), and $48.0 million (Q4 2019), per Business Quant data.